Physician profile
Gareth John Adams
NPI 1750611158
$1,098.34
in general payments reported to CMS, 2019-2025
12 companies · $521 in 2025
The $521 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2021: $54.32 · 2022: $57.38 · 2023: $58.94 · 2024: $40.51 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $272.36 | 2021-2025 | |
| Medtronic, INC. | $192.44 | 2025 | N/A, Intellis Adaptivestim |
| Abbott Laboratories | $164.57 | 2019-2025 | Eterna |
| Genentech USA, INC. | $119.57 | 2019 | |
| Medical Device Business Services, INC. | $115.22 | 2019 | |
| Eisai INC. | $58.71 | 2023-2025 | |
| Boston Scientific Corporation | $40.51 | 2024 | Vercise |
| Integra Lifesciences Corporation | $33.38 | 2022 | |
| Biotronik Nro, INC. | $31.92 | 2025 | Prospera |
| Depuy Synthes Sales INC. | $31.50 | 2023 | Matrixneuro |
| Alphatec Spine, INC | $24.00 | 2022 | |
| Merck Sharp & Dohme LLC | $14.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gareth Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.